Epigenetics and Fibrosis: Lessons, Challenges, and Windows of Opportunity

Bin Liu, Xin Sheng Wang, Hui Min Chen, Lu Qianjin, M. Eric Gershwin, Patrick S Leung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Fibrosis is a serious health problem characterized by overgrowth, hardening, and/or scarring of tissues, due to excess accumulation of extracellular matrix and could lead to organ malfunction. Fibrotic diseases include a wide spectrum of clinical entities of unknown etiology. Although no effective antifibrotic treatment is available, increasing evidence has demonstrated the involvement of epigenetics. The clinical management of fibrotic diseases is largely hindered by the lack of disease-specific diagnosis biomarkers and therapeutic targets. Here we review recent studies on the epigenetic regulation of fibrosis, with emphasis on fibrosis of the lung, liver, and skin. Epigenetic control of the cellular phenotype in the context of tissue injury and aberrant tissue remodeling offers new insights into the pathogenesis of fibrosis. Knowledge gained on epigenetic regulation provides promising leads for the development of precise predictive diagnosis markers and possibly targeted therapy in the future.

Original languageEnglish (US)
Title of host publicationEpigenetics and Dermatology
PublisherElsevier Inc.
Pages53-74
Number of pages22
ISBN (Print)9780128012727, 9780128009574
DOIs
StatePublished - Feb 17 2015

Fingerprint

Epigenomics
Fibrosis
Tissue
Biomarkers
Medical problems
Choristoma
Liver
Hardening
Skin
Disease Management
Liver Cirrhosis
Cicatrix
Extracellular Matrix
Phenotype
Lung
Health
Wounds and Injuries
Therapeutics

Keywords

  • DNA methylation
  • Epigenetics
  • Fibrosis
  • Histone modifications
  • Liver
  • Lung
  • Skin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Liu, B., Wang, X. S., Chen, H. M., Qianjin, L., Gershwin, M. E., & Leung, P. S. (2015). Epigenetics and Fibrosis: Lessons, Challenges, and Windows of Opportunity. In Epigenetics and Dermatology (pp. 53-74). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800957-4.00004-7

Epigenetics and Fibrosis : Lessons, Challenges, and Windows of Opportunity. / Liu, Bin; Wang, Xin Sheng; Chen, Hui Min; Qianjin, Lu; Gershwin, M. Eric; Leung, Patrick S.

Epigenetics and Dermatology. Elsevier Inc., 2015. p. 53-74.

Research output: Chapter in Book/Report/Conference proceedingChapter

Liu, B, Wang, XS, Chen, HM, Qianjin, L, Gershwin, ME & Leung, PS 2015, Epigenetics and Fibrosis: Lessons, Challenges, and Windows of Opportunity. in Epigenetics and Dermatology. Elsevier Inc., pp. 53-74. https://doi.org/10.1016/B978-0-12-800957-4.00004-7
Liu B, Wang XS, Chen HM, Qianjin L, Gershwin ME, Leung PS. Epigenetics and Fibrosis: Lessons, Challenges, and Windows of Opportunity. In Epigenetics and Dermatology. Elsevier Inc. 2015. p. 53-74 https://doi.org/10.1016/B978-0-12-800957-4.00004-7
Liu, Bin ; Wang, Xin Sheng ; Chen, Hui Min ; Qianjin, Lu ; Gershwin, M. Eric ; Leung, Patrick S. / Epigenetics and Fibrosis : Lessons, Challenges, and Windows of Opportunity. Epigenetics and Dermatology. Elsevier Inc., 2015. pp. 53-74
@inbook{303533b4e96a4dba9af51be6d8ae2a3b,
title = "Epigenetics and Fibrosis: Lessons, Challenges, and Windows of Opportunity",
abstract = "Fibrosis is a serious health problem characterized by overgrowth, hardening, and/or scarring of tissues, due to excess accumulation of extracellular matrix and could lead to organ malfunction. Fibrotic diseases include a wide spectrum of clinical entities of unknown etiology. Although no effective antifibrotic treatment is available, increasing evidence has demonstrated the involvement of epigenetics. The clinical management of fibrotic diseases is largely hindered by the lack of disease-specific diagnosis biomarkers and therapeutic targets. Here we review recent studies on the epigenetic regulation of fibrosis, with emphasis on fibrosis of the lung, liver, and skin. Epigenetic control of the cellular phenotype in the context of tissue injury and aberrant tissue remodeling offers new insights into the pathogenesis of fibrosis. Knowledge gained on epigenetic regulation provides promising leads for the development of precise predictive diagnosis markers and possibly targeted therapy in the future.",
keywords = "DNA methylation, Epigenetics, Fibrosis, Histone modifications, Liver, Lung, Skin",
author = "Bin Liu and Wang, {Xin Sheng} and Chen, {Hui Min} and Lu Qianjin and Gershwin, {M. Eric} and Leung, {Patrick S}",
year = "2015",
month = "2",
day = "17",
doi = "10.1016/B978-0-12-800957-4.00004-7",
language = "English (US)",
isbn = "9780128012727",
pages = "53--74",
booktitle = "Epigenetics and Dermatology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Epigenetics and Fibrosis

T2 - Lessons, Challenges, and Windows of Opportunity

AU - Liu, Bin

AU - Wang, Xin Sheng

AU - Chen, Hui Min

AU - Qianjin, Lu

AU - Gershwin, M. Eric

AU - Leung, Patrick S

PY - 2015/2/17

Y1 - 2015/2/17

N2 - Fibrosis is a serious health problem characterized by overgrowth, hardening, and/or scarring of tissues, due to excess accumulation of extracellular matrix and could lead to organ malfunction. Fibrotic diseases include a wide spectrum of clinical entities of unknown etiology. Although no effective antifibrotic treatment is available, increasing evidence has demonstrated the involvement of epigenetics. The clinical management of fibrotic diseases is largely hindered by the lack of disease-specific diagnosis biomarkers and therapeutic targets. Here we review recent studies on the epigenetic regulation of fibrosis, with emphasis on fibrosis of the lung, liver, and skin. Epigenetic control of the cellular phenotype in the context of tissue injury and aberrant tissue remodeling offers new insights into the pathogenesis of fibrosis. Knowledge gained on epigenetic regulation provides promising leads for the development of precise predictive diagnosis markers and possibly targeted therapy in the future.

AB - Fibrosis is a serious health problem characterized by overgrowth, hardening, and/or scarring of tissues, due to excess accumulation of extracellular matrix and could lead to organ malfunction. Fibrotic diseases include a wide spectrum of clinical entities of unknown etiology. Although no effective antifibrotic treatment is available, increasing evidence has demonstrated the involvement of epigenetics. The clinical management of fibrotic diseases is largely hindered by the lack of disease-specific diagnosis biomarkers and therapeutic targets. Here we review recent studies on the epigenetic regulation of fibrosis, with emphasis on fibrosis of the lung, liver, and skin. Epigenetic control of the cellular phenotype in the context of tissue injury and aberrant tissue remodeling offers new insights into the pathogenesis of fibrosis. Knowledge gained on epigenetic regulation provides promising leads for the development of precise predictive diagnosis markers and possibly targeted therapy in the future.

KW - DNA methylation

KW - Epigenetics

KW - Fibrosis

KW - Histone modifications

KW - Liver

KW - Lung

KW - Skin

UR - http://www.scopus.com/inward/record.url?scp=84940021840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940021840&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800957-4.00004-7

DO - 10.1016/B978-0-12-800957-4.00004-7

M3 - Chapter

AN - SCOPUS:84940021840

SN - 9780128012727

SN - 9780128009574

SP - 53

EP - 74

BT - Epigenetics and Dermatology

PB - Elsevier Inc.

ER -